Analysis of failure patterns in patients with resectable esophageal squamous cell carcinoma receiving chemoradiotherapy

被引:6
|
作者
Shen, Wen-Bin [1 ]
Zhu, Shu-Chai [1 ]
Gao, Hong-Mei [2 ]
Li, You-Mei [1 ]
Su, Jin-Wei [1 ]
Li, Juan [1 ]
Liu, Zhi-Kun [1 ]
机构
[1] Hebei Med Univ, Hosp 4, Dept Radiat Oncol, 12th Jiankan Rd, Shijiazhaung 050011, Peoples R China
[2] First Hosp Shijiazhaung, Dept Radiat, Shijiazhaung, Peoples R China
关键词
Chemoradiotherapy; esophageal squamous cell carcinoma; factor analysis; failure pattern; EXTENDED RADICAL ESOPHAGECTOMY; RADIATION-THERAPY; RECURRENCE; CANCER; RADIOTHERAPY; CHEMORADIATION; CHEMOTHERAPY; RESECTION;
D O I
10.4103/0973-1482.146128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study investigates the failure pattern after chemoradiotherapy of patients with resectable esophageal squamous cell carcinoma (ESCC). Materials and Methods: We retrospectively analyzed 92 patients with T1-2, N0-1, and M0 ESCC. These patients were inoperable because of poor performance, comorbidities, poor tumor region, or refusal of operation. Results: Among the 92 patients, 29 cases displayed simple locoregional recurrence, 12 cases displayed simple distant metastasis, and 6 cases displayed distant metastasis with locoregional recurrence. Univariate analysis shows that the incidence of recurrence in the middle thoracic region was significantly higher than other regions (chi(2) = 14.415, P = 0.001). For the 18 patients with distant metastasis, incidence of distant metastasis in the lower thoracic region was significantly higher than the other regions (chi(2) = 39.359, P < 0.001). Among 35 cases with regional recurrence, 7 cases reached complete remission (14.6%) and 28 cases reached partial remission (PR; 63.6%) (chi(2) = 23.435, P < 0.001). Multivariate analysis shows that the patient age, tumor node metastasis (TNM) stage, and short-term efficacy were independent factors for locoregional recurrence. Patient age, TNM stage, X-ray length of the lesions, and short-term efficacy were the independent factors for distant metastases. Conclusion: The incidence of locoregional recurrence and distant metastasis in patients with upper thoracic esophageal cancer was lower than those who had middle thoracic and lower thoracic esophageal cancer. The incidence of locoregional recurrence and distant metastasis in patients who achieved complete response after treatment was low.
引用
收藏
页码:62 / 68
页数:7
相关论文
共 50 条
  • [41] Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis
    Jin, Hai-Lin
    Zhu, Hong
    Ling, Ting-Sheng
    Zhang, Hong-Jie
    Shi, Rui-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (47) : 5983 - 5991
  • [42] Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy
    Wang, Qian
    Qiu, Qingtao
    Zhang, Zicheng
    Zhang, Jing
    Yang, Guanghui
    Liu, Chengxin
    Li, Baosheng
    CANCER MEDICINE, 2021, 10 (17): : 5847 - 5858
  • [44] Clinical outcomes in patients with resectable esophageal squamous cell carcinoma with supraclavicular lymph node metastasis: Surgery versus definitive chemoradiotherapy
    Homma, Y.
    Kato, K.
    Hamaguchi, T.
    Yamada, Y.
    Shimada, Y.
    Hokamura, N.
    Igaki, H.
    Tachimori, Y.
    Ito, Y.
    Itami, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S583 - S584
  • [45] Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
    Chen, Baoqing
    Liu, Shiliang
    Zhu, Yujia
    Wang, Ruixi
    Cheng, Xingyuan
    Chen, Biqi
    Dragomir, Mihnea P.
    Zhang, Yaru
    Hu, Yonghong
    Liu, Mengzhong
    Li, Qiaoqiao
    Yang, Hong
    Xi, Mian
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [46] Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimab
    Baoqing Chen
    Shiliang Liu
    Yujia Zhu
    Ruixi Wang
    Xingyuan Cheng
    Biqi Chen
    Mihnea P. Dragomir
    Yaru Zhang
    Yonghong Hu
    Mengzhong Liu
    Qiaoqiao Li
    Hong Yang
    Mian Xi
    Nature Communications, 15
  • [47] The implication of failure patterns after neoadjuvant chemoradiotherapy with small involved-field in esophageal squamous cell carcinoma.
    Shin, Hyunju
    Oh, Dongryul
    Noh, Jae Myoung
    Yang, Kyungmi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 376 - 376
  • [48] Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Nobuhiro Tsuchiya
    Chikara Kunisaki
    Sho Sato
    Yusaku Tanaka
    Kei Sato
    Jun Watanabe
    Kazuhisa Takeda
    Takashi Kosaka
    Hirotoshi Akiyama
    Itaru Endo
    Langenbeck's Archives of Surgery, 2022, 407 : 1911 - 1921
  • [49] Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma
    Yi, Yan
    Li, Baosheng
    Sun, Hongfu
    Zhang, Zicheng
    Gong, Heyi
    Li, Hongsheng
    Huang, Wei
    Wang, Zhongtang
    TUMOR BIOLOGY, 2010, 31 (04) : 333 - 340
  • [50] Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
    Suzuki, Yugo
    Kikuchi, Daisuke
    Hoteya, Shu
    Okamura, Takayuki
    Ochiai, Yorinari
    Hayasaka, Junnosuke
    Dan, Nobuhiro
    Mitsunaga, Yutaka
    Tanaka, Masami
    Odagiri, Hiroyuki
    Nomura, Kosuke
    Yamashita, Satoshi
    Matsui, Akira
    Iizuka, Toshiro
    DIGESTION, 2021, 102 (04) : 622 - 629